new hope for ovarian cancer1 min read

ONX-0801 is the first in a new class of drugs discovered at the UK’s Institute for Cancer Research.

The drug attacks ovarian cancer by mimicking folic acid to enter the cancer cells.

The drug then kills these cells by blocking a molecule called thymidylate synthase, thereby causing irreparable DNA damage.

The ICR’s Udai Banerji, who led the study, said much more research was needed but the results were exciting